| Identification | Back Directory | [Name]
2'',3''-DIHYDRO-2''-OXOSPIRO-[PIPERIDINE-4,4''(1H'')-QUINAZOLINE | [CAS]
635713-68-7 | [Synonyms]
1'H-Spiro[piperidine-4,4'-quinazolin]-2'(3'H)-one Spiro[piperidine-4,4'(1'H)-quinazolin]-2'(3'H)-one spiro[1,3-dihydroquinazoline-4,4'-piperidine]-2-one 1'H-spiro[piperidine-4,4'(1'H)-quinazolin]-2'(3'H)-one 2'',3''-DIHYDRO-2''-OXOSPIRO-[PIPERIDINE-4,4''(1H'')-QUINAZOLINE | [Molecular Formula]
C12H15N3O | [MDL Number]
MFCD11045505 | [MOL File]
635713-68-7.mol | [Molecular Weight]
217.27 |
| Chemical Properties | Back Directory | [Boiling point ]
371.3±42.0 °C(Predicted) | [density ]
1.26±0.1 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2–8 °C | [pka]
11.77±0.20(Predicted) |
| Hazard Information | Back Directory | [Synthesis]
The general procedure for the synthesis of 1'H-spiro[piperidine-4,4'-quinazolin]-2'(3'H)-ones was carried out as follows, using 1-benzyl-1'H-spiro[piperidine-4,4'-quinazolin]-2'(3'H)-ones as starting material: 1-benzyl-1'H-spiro[piperidine-4,4'-quinazolin]-2'(3'H)-ones (1.00 g) were dissolved in degassed methanol (50 ml ), 6N hydrochloric acid (2.0 ml) was added followed by 10% palladium carbon catalyst (150 mg). The reaction mixture was placed in a Parr hydrogenation unit and the reaction was shaken at 60 psi hydrogen pressure overnight. The progress of the reaction was monitored by LC/MS and the reaction was found to be incomplete. The 10% palladium carbon catalyst (200 mg) was added additionally and the reaction was continued with oscillation under the same conditions for 2 days. Upon completion of the reaction, the catalyst was removed by filtration and the filtrate was concentrated to afford the target product 1'H-spiro[piperidin-4,4'-quinazolin]-2'(3'H)-one (531 mg, 64% yield). Mass spectrometry analysis showed a molecular ion peak of 218.12 (MH+). | [References]
[1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 14, p. 4719 - 4722 [2] Patent: WO2003/104236, 2003, A1. Location in patent: Page 58 [3] Patent: US2005/215576, 2005, A1. Location in patent: Page/Page column 19 |
|
| Company Name: |
NovoChemy Ltd.
|
| Tel: |
021-31261262/ 49 (0)17662837245 |
| Website: |
www.novochemy.com |
| Company Name: |
Cool Pharm, Ltd
|
| Tel: |
021-60455363 18019463053 |
| Website: |
www.coolpharm.com |
|